← Back to Search

Behavioral Intervention

Behavior Change Therapy for Cancer Risk Behaviors (STELLAR Trial)

N/A

Waitlist Available

Led By Sofia Garcia, PhD

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3, 6, 9 and 12 months

Awards & highlights

STELLAR Trial Summary

This trial seeks to improve cancer survivors' health and quality of life by combining physical activity promotion, smoking cessation and obesity treatment into one intervention program. Participants will track their health behaviors and be assessed at baseline, 3, 6 and 12 months.

Who is the study for?

The STELLAR trial is for Northwestern Medicine cancer survivors over 18, who are not very active (less than 150 minutes of exercise per week), have a BMI of ≥25, or smoke daily. They must be able to attend telehealth visits and speak English or Spanish. People with severe health issues, those in other similar interventions, or pregnant women can't join.Check my eligibility

What is being tested?

STELLAR tests a combined intervention program against enhanced usual care to see if it better improves physical activity, smoking cessation, and obesity treatment among cancer survivors. It includes tracking health behaviors and attending telehealth sessions to discuss progress towards goals.See study design

What are the potential side effects?

Since this trial involves behavior change therapy through telehealth sessions rather than medication or medical procedures, there are no direct side effects like you'd expect from drugs; however participants may experience discomfort adjusting to new lifestyle changes.

STELLAR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3, 6, 9 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3, 6, 9 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reach/Access

Secondary outcome measures

Body Weight

Godin Leisure Time Exercise Questionnaire

Rating of Care Quality as Measured by the Consumer Assessment of Healthcare Providers & Systems Cancer Care Survey)

+6 more

STELLAR Trial Design

2Treatment groups

Active Control

Group I: STELLAR ProgramActive Control1 Intervention

STELLAR arm participants will receive goals related to their physical activity, smoking, and/or obesity, and will be asked to meet those goals weekly/daily. Participants will also be asked to record their weight, activity, and/or cigarette smoking daily, and will complete 16 telehealth sessions with study staff across the 12 months of the study. Will have physical measures taken or extracted from the medical record at baseline, 3 months, 6 months, and 12 months.

Group II: Enhanced Usual CareActive Control1 Intervention

Patients in the EUC group will receive informational packets about their risk behaviors - obesity, physical inactivity, and/or smoking. Will have physical measures taken or extracted from the medical record at baseline, 3 months, 6 months, and 12 months

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor

1,585 Previous Clinical Trials

914,231 Total Patients Enrolled

32 Trials studying Obesity

8,332 Patients Enrolled for Obesity

Sofia Garcia, PhDPrincipal InvestigatorNorthwestern University

Bonnie Spring, PhDPrincipal InvestigatorNorthwestern University

9 Previous Clinical Trials

2,536 Total Patients Enrolled

1 Trials studying Obesity

492 Patients Enrolled for Obesity

Media Library

STELLAR Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05687604 — N/A

Obesity Research Study Groups: STELLAR Program, Enhanced Usual Care

Obesity Clinical Trial 2023: STELLAR Program Highlights & Side Effects. Trial Name: NCT05687604 — N/A

STELLAR Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05687604 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for participants in this trial?

"Clinicaltrials.gov suggests that this particular medical trial is currently not actively recruiting participants, with the last date of updating being on January 6th 2023. Although it no longer requires new candidates, there are a plethora of other clinical trials still seeking volunteers in numerous fields of medicine."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

Bonnie Spring 2023. "Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05687604.